ReviewInvestigational new drugs2025
Sunvozertinib: a Promising Oral EGFR Inhibitor Approved for NSCLC with EGFR Ex20ins Mutations.
Kavita Sangwan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewInvestigational new drugs2025
Kavita Sangwan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.